← Back to Events
ONCOLOGY CONCLUDED
2026 Clinical Advances
Conference to evaluate recent practice-changing clinical trial data and guideline updates in solid and hematologic malignancies to inform evidence-based treatment decisions (6.50 credits).[9]
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
🇺🇸 Latest Americas News
All news → May 4 Clene Receives FDA Green Light for CNM-Au8 Accelerated Approval Pathway in ALS Treatment May 4 Alpha Tau's Alpha DaRT Achieves 100% Local Disease Control in Pancreatic Cancer Trials at DDW 2026 May 4 Takeda's TAK-881 Shows Positive Phase 2/3 Results for Primary Immunodeficiency Disease Treatment May 4 Accord Healthcare Relaunches Tadalafil Tablets in Multiple Dosage Strengths, Expanding Generic ED Treatment Access May 4 InspireMD Receives FDA Approval for SwitchGuard Neuro Protection System CGUARDIANS III Pivotal Trial